Cover image of Plenary Session

Plenary Session

A podcast on medicine, oncology, & health policy. Host: Vinay Prasad, MD MPH from University of California San Francisco.Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Popular episodes

All episodes

The best episodes ranked using user listens.

Podcast cover

2.19 Remembering Dr. Bernard Fisher & Self-Diagnosis with Dr. Mark Lewis

This week we give a short monologue on the late Dr. Bernard Fisher's legacy in the field of oncology, and then dive into a far-ranging interview with Dr. Mark Lewis of Intermountain Healthcare on his career, his family, and diagnosing himself with MEN1 syndrome. Dr. Fisher's obituary in the New York Times: https://www.nytimes.com/2019/10/19/science/dr-bernard-fisher-dead.htmlBack us on Patreon! www.patreon.com/plenarysession

2hr 13mins

25 Oct 2019

Rank #1

Podcast cover

1.03: RWE, Right to Try, Talazoparib, Nivolumab, and Dr. Andrae Vandross

We're moving to our new format. We begin with a monologue of the most noteworthy articles in this week's news. We'll be talking about real-world evidence, Right to Try, talazoparib, and the FDA approval for nivolumab in small-cell lung cancer. In the second half of the show, we'll interview Dr. Andrae Vandross, a community oncologist at UCLA Medical Center.

1hr 6mins

21 Aug 2018

Rank #2

Similar Podcasts

Podcast cover

2.28 Trastuzumab in Later Lines of Therapy for HER2+ Breast Cancer, Kaplan-Meier Curves, & Patreon

We're back in Plenary Session HQ! We have multiple topics for you this week. We cover the use of trastuzumab in later lines of therapy for HER2+ metastatic breast cancer, we take a listener question on Kaplan-Meier curves, and we talk a little about Patreon.Malignant: www.amazon.com/Malignant-Policy-Evidence-People-Cancer/dp/1421437635Back us on Patreon! www.patreon.com/plenarysession

1hr 3mins

20 Dec 2019

Rank #3

Podcast cover

2.07 Translational Research & Physical Examination Pet Peeves with Dr. Adam Cifu

We start this week's episode with a Question of the Week from medical student Audrey Tran on translational research and medical student training. Afterwards, we have an in-depth interview with Dr. Adam Cifu of the University of Chicago on his recent publication: "Physical Examination Pet Peeves". Pet Peeves: doi.org/10.4300/JGME-D-18-01063.1Back us on Patreon! www.patreon.com/plenarysession

1hr 17mins

16 Aug 2019

Rank #4

Most Popular Podcasts

Podcast cover

1.04: Nutritional Epi, Lenvatinib, Nivo and Ipi for Melanoma, and Dr. Avi O'Glasser

This week's episode is on nutritional epidemiology by JPA Ioannidis; lenvatinib for hepatocellular carcinoma; nivolumab and ipilimumab for melanoma; and #medtwitter with Dr. Avi O Glasser from OHSU.


30 Aug 2018

Rank #5

Podcast cover

1.30 BONUS! Clinical Trial Endpoints, Drug Approval, Incentives in Oncology

This BONUS episode is the recording of a lecture given to the National Breast Cancer Coalition on December 11, 2018. It's on clinical trial endpoints, FDA drug approval, and incentives in oncology. Backers of our Patreon will be sent accompanying slides.Back us on Patreon! www.patreon.com/plenarysession

1hr 10mins

19 Dec 2018

Rank #6

Podcast cover

3.32 Publishing Original Thought in Medical Journals with Dr. Stephen Bradley

Today we talk with Dr. Stephen Bradley, a General Practitioner and Clinical Research Fellow at the University of Leeds, on publishing in medical journals -- peer review, editorial practices, anti-intellectualism, and more!Notes on Nationalism: www.orwellfoundation.com/the-orwell-foundation/orwell/essays-and-other-works/notes-on-nationalism/Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew


8 Jan 2021

Rank #7

Podcast cover

1.42 Caplacizumab for TTP with Dr. Sven Olson & Economics of Drug Pricing with Dr. Inma Hernández

In the first half of this episode, Dr. Sven Olson of OHSU joins us to help critique the recent NEJM paper, "Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura". In the second half, we interview Dr. Inmaculada Hernández of the University of Pittsburgh on her work on the economic principles behind runaway drug prices.Caplacizumab: doi.org/10.1056/NEJMoa1806311Back us on Patreon! www.patreon.com/plenarysession

1hr 16mins

13 Feb 2019

Rank #8

Podcast cover

2.30 Questions from a Medical Student & Epidemiology with Dr. Ellie Murray

This week we return to our discussion of going after soft targets vs hard targets, but this time with a focus on how it applies to building a burgeoning career in medicine, in our segment Questions from a Medical Student with Audrey Tran. We end this week's episode with a far-reaching interview with Dr. Ellie Murray (most people know her as Epi Ellie on Twitter and as the co-host of the podcast Casual Inference) on all things epidemiology.Check out Dr. Murray's excellent podcast here: https://casualinfer.libsyn.com/Back us on Patreon! www.patreon.com/plenarysession

1hr 47mins

3 Jan 2020

Rank #9

Podcast cover

1.46 BONUS! Personal Finances with Dr. Tom Beer

In this bonus episode, we bring back Dr. Tom Beer of OHSU from episode 1.33 to discuss how to manage your personal finances. The interview is aimed at young physicians, but there is something for all audiences as we cover a broad range of topics: paying off loans, optimizing retirement savings, buying a home, and investing.Back us on Patreon! www.patreon.com/plenarysession

1hr 16mins

8 Mar 2019

Rank #10

Podcast cover

1.37 BONUS! Medical Reversal for a General Audience

This BONUS episode is the recording of a talk given at the Salem City Club on January 11, 2019. It's the talk on medical reversal that has been featured in previous episodes, but this time the format and content have been updated for a broader, more general audience.Back us on Patreon! www.patreon.com/plenarysession


18 Jan 2019

Rank #11

Podcast cover

1.17 BONUS! Interpretation of Cancer Clinical Trials

This BONUS episode is the recording of a two-part talk addressed to oncology fellows given at Oregon Health & Science University on October 5 and October 12, 2018. The talk is on how to interpret cancer clinical trials.

1hr 18mins

22 Oct 2018

Rank #12

Podcast cover

3.42 Overdiagnosis and Cutaneous Melanoma Diagnoses with Dr. Adewole Adamson and Dr. Benjamin Mazer

For today's episode, we sit down with Drs. Ade Adamson of the University of Texas at Austin Dell Medical School and Ben Mazer of Johns Hopkins Hospital to discuss their new paper out now in the New England Journal of Medicine titled "The Rapid Rise in Cutaneous Melanoma Diagnoses". It's one of the best papers you'll read all year.Melanoma Diagnoses: doi.org/10.1056/NEJMsb2019760Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew

1hr 6mins

10 Feb 2021

Rank #13

Podcast cover

1.52 BILCAP & DOACs for Thromboprophylaxis in Patients with Cancer with Dr. Sven Olson

In this week's episode we critique the statistics of the recent trial "Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study" that was published in The Lancet Oncology. Then, with Dr. Sven Olson of OHSU, we break down the two papers published in NEJM on thromboprophylaxis with direct oral anticoagulants (DOACs) for patients with cancer: "Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer" and "Apixaban to Prevent Venous Thromboembolism in Patients with Cancer". BILCAP: www.thelancet.com/journals/lanonc/article/PIIS1470-2045(18)30915-XRivaroxaban: doi.org/10.1056/NEJMoa1814630Apixaban: doi.org/10.1056/NEJMoa1814468Back us on Patreon! www.patreon.com/plenarysession


4 Apr 2019

Rank #14

Podcast cover

2.40 BEACON part 2, NALA, & Molecular Pathology and Next-Generation Sequencing with Dr. David Carr

This week we revisit BEACON! The authors of the BEACON study have responded to the Letter to the Editor our host Dr. Vinay Prasad submitted to the New England Journal of Medicine, and we share our thoughts on what they said. We then turn to the FDA's recent approval of neratinib in combination with capecitabine for HER2-positive breast cancer, based on the phase III NALA trial. Finally, we interview Dr. David Carr, a Molecular Pathology Fellow at UC San Diego, on his work in general and, specifically, next-generation sequencing.BEACON Letters to the Editor: www.nejm.org/doi/full/10.1056/NEJMoa1908075#article_lettersNALA: https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-neratinib-metastatic-her2-positive-breast-cancerVinay's new book, Malignant: www.amazon.com/Malignant-Policy-…cer/dp/1421437635Back us on Patreon! www.patreon.com/plenarysession

1hr 9mins

5 Mar 2020

Rank #15

Podcast cover

3.36 Sustainable Ex-Vivo Seafood with Dr. Arye Elfenbein

On today's episode we sit down with Dr. Arye Elfenbein, a cardiologist and "doctorpreneur " to interview him on the bio-tech company he recently co-founded: Wildtype. Wildtype manufactures ex-vivo fish meat for human consumption in fulfillment of their mission to create the cleanest, most sustainable seafood.Back us on Patreon! www.patreon.com/plenarysessionCheck out our YouTube channel: www.youtube.com/channel/UCUibd0E2kdF9N9e-EmIbUew


22 Jan 2021

Rank #16

Podcast cover

1.05 Cost and Efficacy of Cancer Drugs, ECHELON-1, Dr. Derrick Tao, and EBM with Dr. Martha Gerrity

In this episode we cover the cost and efficacy of cancer drugs; review ECHELON-1; interview Dr. Derrick Tao of OHSU about his recent Lancet Oncology paper on poor control arms; and discuss evidence-based medicine with EBM expert and internist at OHSU, Dr. Martha Gerrity.


5 Sep 2018

Rank #17

Podcast cover

1.24 Useless Medical Conferences and Dr. Adam Obley on Vascepa, Fish Oil, Vitamin D and Methotrexate

In this episode we discuss John Ioannidis' article on the uselessness of medical conferences, published in JAMA: "Are Medical Conferences Useful? And for Whom?", followed by an interview with return-guest Dr. Adam Obley on a few recent clinical trials: Vascepa, fish oil, vitamin D, and methotrexate.Medical conferences: doi.org/10.1001/jama.2012.360


20 Nov 2018

Rank #18

Podcast cover

1.58 Magic Mouthwash with Dr. Arjun Gupta & Precision Oncology with Dr. Talal Hilal

This week we discuss three paired papers on precision oncology published in Nature Medicine and then, later in the episode, go in-depth on the implications of these negative studies with Dr. Talal Hilal of the Mayo Clinic. We also discuss the use of magic mouthwash for oral mucositis with Plenary Session fan, Dr. Arjun Gupta of Johns Hopkins University. WINTHER: doi.org/10.1038/s41591-019-0424-4TARGET: doi.org/10.1038/s41591-019-0380-zI-PREDICT: doi.org/10.1038/s41591-019-0407-5Magic mouthwash: doi.org/10.1001/jamainternmed.2018.6223Back us on Patreon! www.patreon.com/plenarysession

1hr 34mins

7 May 2019

Rank #19

Podcast cover

2.25 Questions of the Week: Hematology/Oncology, the USMLE Step 2 CK, & One From a Med Student

Our host is still out of town, but don't worry -- we have some questions of the week to tide you over. The first is inspired by the hematology/oncology boards, presented by Dr. Sven Olson; the second is inspired by the USMLE Step 2 CK, presented by Ian Straehley; and the third is from Audrey Tran, inspired by her experiences as a med student.Back us on Patreon! www.patreon.com/plenarysession


2 Dec 2019

Rank #20